Efectos a largo plazo del programa PROCONI en preescolares de Tunja (Colombia)
Informes psicológicos · 2019
DOI: 10.18566/infpsic.v19n1a05 ↗Kurz gefasst
Fachartikel in der Zeitschrift Informes psicológicos, 2019. Verfasst von Lucía Carlota Rodríguez Barreto und 1 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Objective
The long-term impact of the Children's Neuropsychological Correction Program, PROCONI, was evaluated 3 years after it was implemented.
Method
An experimental prospective study was carried out in a cohort of 38 boys and girls, of whom 52.4% (22) were male and 47.6% (20) female. The participants were between 5 and 7 years old (M = 7.12, SD = .96), belonging to schools in the urban and rural areas of the city of Tunja.
Results
In urban and rural participants, it was found that neurodevelopment scores were in accordance with their age and schooling. These scores were evaluated with CUMANIN or CUMANES respectively, and statistically significant correlations were found that ranged from moderate to strong in the performance of follow-up evaluations in most of the areas stimulated.
Discussion
The implementation of the PROCONI program of neuropsychological stimulation can have significant long-term effects in order to prevent learning difficulties, school failure and social adjustment in areas of neuropsychological maturity.
Zitieren
APA
Barreto, L. C. R., & Pulido, J. H. P. (2019). Efectos a largo plazo del programa PROCONI en preescolares de Tunja (Colombia). Informes psicológicos. https://doi.org/10.18566/infpsic.v19n1a05
Vancouver
Barreto LCR, Pulido JHP. Efectos a largo plazo del programa PROCONI en preescolares de Tunja (Colombia). Informes psicológicos. 2019. doi:10.18566/infpsic.v19n1a05
BibTeX
@article{Barreto2019,
author = {Barreto, Lucía Carlota Rodríguez and Pulido, Javier Humberto Parra},
title = {Efectos a largo plazo del programa PROCONI en preescolares de Tunja (Colombia)},
journal = {Informes psicológicos},
year = {2019},
doi = {10.18566/infpsic.v19n1a05}
}
EUVIMED